Compounds > nicardipine

nicardipine and ae0047

nicardipine has been researched along with ae0047 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishikawa, M; Okamura, T; Toda, N; Yoshida, K1
Hayashi, K; Kido, H; Shinyama, H; Uchida, T; Watanabe, M1
Ebisu, H; Egi, Y; Fujino, Y; Hayashi, K; Inoue, S; Kido, H; Kubo, Y; Nakamura, N; Nishikawa, M; Ohtaki, Y; Uchida, T; Yamanaga, K1
Kagitani, Y; Kawamura, T; Nagai, H; Nakamura, N; Narita, Y; Shinyama, H1
Gohda, M; Kido, H; Matzno, S; Nakamura, N; Nishikawa, M; Shinyama, H; Yamanaga, K1
Hayashi, K; Matsumura, Y; Ohmagari, M; Tamai, I; Yamasaki, T1

Other Studies

6 other study(ies) available for nicardipine and ae0047

ArticleYear
AE0047, a new dihydropyridine Ca2+ entry blocker, inhibits the responses to adrenergic nerve stimulation and substance P in dog mesenteric arteries.
    European journal of pharmacology, 1992, Sep-10, Volume: 220, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Calcium Channel Blockers; Cyclic GMP; Dihydropyridines; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Mesenteric Arteries; Nicardipine; Substance P; Sympathetic Nervous System; Tritium; Vasodilation

1992
Effects of AE0047 on renal haemodynamics and function in anaesthetized dogs.
    Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:2

    Topics: Anesthesia; Animals; Calcium Channel Blockers; Dihydropyridines; Diuresis; Dogs; Hemodynamics; Infusions, Intra-Arterial; Injections, Intravenous; Kidney; Natriuresis; Nicardipine; Renal Artery

1993
[Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1997, Volume: 109, Issue:6

    Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Desoxycorticosterone; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Hypertension, Renal; Injections, Intravenous; Nicardipine; Nitrendipine; Rats; Rats, Inbred SHR

1997
Therapeutic effects of AE0047, a novel calcium antagonist, on progression of brain damage after stroke in stroke-prone spontaneously hypertensive rats.
    General pharmacology, 1998, Volume: 30, Issue:3

    Topics: Animals; Brain; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Hydralazine; Male; Nicardipine; Rats; Rats, Inbred SHR; Vasodilator Agents

1998
Calcium channel blocking and vasodilating actions of the novel dihydropyridine derivative AE0047.
    Clinical and experimental pharmacology & physiology, 1998, Volume: 25, Issue:5

    Topics: Animals; Antihypertensive Agents; Aorta; Binding Sites; Binding, Competitive; Calcium; Calcium Channel Blockers; Cattle; Dihydropyridines; Dose-Response Relationship, Drug; Guinea Pigs; Heart Ventricles; Nicardipine; Nitrendipine; Patch-Clamp Techniques; Rats; Structure-Activity Relationship; Vasodilator Agents

1998
Inhibitory effects of AE0047, a new dihydropyridine Ca(2+) channel blocker, on renal nerve stimulation-induced renal actions in anesthetized dogs.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: Anesthesia; Animals; Calcium Channel Blockers; Dihydropyridines; Dogs; Electric Stimulation; Female; Infusions, Intra-Arterial; Kidney; Male; Nicardipine; Renal Circulation

2000